If someone held 200 or 300 shares and filed a lawsuit, that was their right — but it doesn’t change the fundamentals.

What matters is that the science survived, the platform survived, and the company can finally move forward without distractions.

No shareholder should be shamed for expressing an opinion, even if others disagree. We’re all here because we believe in the molecule, and we’ve all walked different paths to get here.

Time to let the 8-K speak for itself and get back to the mission.